Docetaxel AqVida 80 mg/vial (IV Infusion)
80 mg vial: ৳ 11,000.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Docetaxel trihydrate |
| Company | Aqvida gmbh |
| Also available as |
Title
- Docetaxel AqVida
Categories
- Pharmaceuticals
- Chemotherapy
- Cancer Treatment
Description
- Antineoplastic agent
- Microtubule inhibitor
- Promotes assembly of tubulin
- Stabilizes microtubules
- Inhibits mitosis in cells
- Effective against various tumor cell lines
- Indicated for breast cancer, lung cancer, prostate cancer, gastric adenocarcinoma, squamous cell carcinoma of the head and neck
- Administered intravenously
- Dosage based on cancer type and patient condition
- CYP3A4 substrate
- Contraindicated in patients with neutrophil counts <1500 cells/mm3
- May cause severe hypersensitivity reactions
- Common side effects: infections, neutropenia, anemia, hypersensitivity, neuropathy, nausea, vomiting, mucositis, alopecia, skin reactions, myalgia
- Can cause fetal harm during pregnancy
- Requires careful supervision in patients with hepatic impairment
- No known antidote for overdose
- Belongs to therapeutic class: Cytotoxic Chemotherapy
- Storage temperature: 2°C to 25°C, protected from light
Related Brands
- Docetaxel HEXAL 80 mg/vial (IV Infusion) - sandoz-a-novartis-division
- Docexan 80 mg/vial (IV Infusion) - beacon-pharmaceuticals-plc
- Taxotere 80 mg/vial (IV Infusion) - synovia-pharma-plc
- Daxotel 80 mg/vial (IV Infusion) - drug-international-ltd
- Docefrez 20 mg/vial (IV Infusion) - healthcare-pharmaceuticals-ltd